BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25613126)

  • 1. Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox.
    Eide N; Faye RS; Høifødt HK; Sandstad B; Qvale G; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2015 Feb; 93(1):59-66. PubMed ID: 25613126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy.
    Eide N; Faye RS; Høifødt HK; Sandvik L; Qvale GA; Faber R; Jebsen P; Kvalheim G; Fodstad Ø
    Pathol Oncol Res; 2019 Jan; 25(1):255-262. PubMed ID: 29098521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated tumour cells in bone marrow of patients with uveal melanoma.
    Eide N; Hoifødt HK; Nesland JM; Faye RS; Qvale GA; Faber RT; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2013 Jun; 91(4):343-8. PubMed ID: 22632270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients.
    Eide N; Faye RS; Høifødt HK; Øvergaard R; Jebsen P; Kvalheim G; Fodstad Ø
    Acta Ophthalmol; 2009 Nov; 87(8):830-6. PubMed ID: 19055657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
    Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.
    Flatmark K; Bjørnland K; Johannessen HO; Hegstad E; Rosales R; Hårklau L; Solhaug JH; Faye RS; Søreide O; Fodstad Ø;
    Clin Cancer Res; 2002 Feb; 8(2):444-9. PubMed ID: 11839662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
    Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S
    Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of circulating melanoma cells in uveal melanoma patients by dual-marker immunoenrichment.
    Tura A; Lüke J; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4395-404. PubMed ID: 24970258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
    Kim IK; Lane AM; Gragoudas ES
    Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
    Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
    Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
    Choesmel V; Pierga JY; Nos C; Vincent-Salomon A; Sigal-Zafrani B; Thiery JP; Blin N
    Breast Cancer Res; 2004; 6(5):R556-70. PubMed ID: 15318937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
    Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
    J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
    Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
    Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrow.
    Retz M; Rotering J; Nawroth R; Buchner A; Stöckle M; Gschwend JE; Lehmann J
    Eur Urol; 2011 Aug; 60(2):231-8. PubMed ID: 21190793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients.
    Tura A; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S; Lüke J
    Pigment Cell Melanoma Res; 2016 Sep; 29(5):583-9. PubMed ID: 27390171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
    Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM
    Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
    Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
    Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.